Lexicon Pharmaceuticals
LXRX
LXRX
109 hedge funds and large institutions have $662M invested in Lexicon Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 34 reducing their positions, and 19 closing their positions.
Holders
109
Holders Change
-12
Holders Change %
-9.92%
% of All Funds
2.37%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
10
Increased
29
Reduced
34
Closed
19
Calls
$939K
Puts
$2.87M
Net Calls
-$1.93M
Net Calls Change
+$1.85M
Top Buyers
1 |
OM
1
Opaleye Management
Boston,
Massachusetts
|
$9.31M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$26.7M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$3.41M |
4 |
4
First Manhattan
New York
|
$18.6M |
5 |
5
Nuveen Asset Management
Chicago,
Illinois
|
$1.15M |